Integra director awarded 17,700 RSUs

Clay Shaundra reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Clay Shaundra reported acquisition or exercise transactions in this Form 4 filing.

INTEGRA LIFESCIENCES HOLDINGS CORP director Shaundra Clay received a grant of 17,700 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of IART common stock under the company’s Fifth Amended and Restated 2003 Equity Incentive Plan.

The RSUs vest in full on the one-year anniversary of the May 7, 2026 grant date. Clay elected to defer receipt of the underlying shares, which will be delivered in a single lump sum in the calendar year following the year her service on the Board ends, unless she elected a later year.

Insider Trade Summary

Grant/Award: 17,700 shares

Grant/Award 1 txn

Insider Clay Shaundra

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	17,700	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 17,700 contracts (Direct)

Footnotes (2)

1. F1. Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock.
2. F2. RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. The reporting person elected to defer receipt of the shares underlying the RSUs. In accordance with her deferral election, vested shares will be delivered to the reporting person in one lump sum, in the calendar year next following the calendar year in which the reporting person's termination of service on the Board of Directors occurs (unless the reporting person elected a later calendar year).

Key Figures

RSUs granted: 17,700 units Underlying common shares: 17,700 shares Vesting schedule: One-year cliff vesting

3 metrics

RSUs granted 17,700 units Restricted Stock Units granted to director on May 7, 2026

Underlying common shares 17,700 shares Each RSU represents one share of IART common stock

Vesting schedule One-year cliff vesting RSUs vest in full on the one-year anniversary of May 7, 2026

Key Terms

Restricted Stock Units, Equity Incentive Plan, deferral election, termination of service

4 terms

Restricted Stock Units financial

"Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Incentive Plan financial

"pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

deferral election financial

"The reporting person elected to defer receipt of the shares underlying the RSUs"

termination of service financial

"delivered to the reporting person in one lump sum, in the calendar year next following the calendar year in which the reporting person's termination of service on the Board of Directors occurs"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IART director Shaundra Clay report?

Shaundra Clay reported receiving 17,700 restricted stock units as equity compensation. Each RSU represents a contingent right to one share of Integra LifeSciences common stock, granted under the company’s Fifth Amended and Restated 2003 Equity Incentive Plan.

How many Integra LifeSciences (IART) RSUs were granted to the director?

The director received 17,700 restricted stock units. These RSUs are tied to Integra LifeSciences common stock and represent a significant equity-based component of her Board compensation under the company’s established equity incentive plan framework.

When do Shaundra Clay’s IART restricted stock units vest?

The RSUs vest in full on the one-year anniversary of the May 7, 2026 grant date. This single cliff-vesting schedule means all 17,700 units vest at once after one year of service from the specified grant date.

What does deferral of RSUs mean for the IART director grant?

Clay elected to defer receipt of shares underlying the vested RSUs. Instead of receiving shares at vesting, she will get them in one lump sum in the calendar year after her Board service ends, unless she chose a later calendar year.

Does the IART Form 4 show a stock purchase or sale by the director?

The Form 4 reflects a grant or award acquisition of RSUs, not an open-market stock purchase or sale. It records compensation granted to the director, with no related share sales or cash purchases reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 04:39 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Clay Shaundra

(Last) (First) (Middle)

1100 CAMPUS ROAD

(Street)

PRINCETON NEW JERSEY 08540

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INTEGRA LIFESCIENCES HOLDINGS CORP [ IART ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	05/07/2026		A		17,700		(2)	(2)	Common Stock	17,700	$0	17,700	D

Explanation of Responses:

1. Grant of restricted stock units (RSUs) pursuant to the Integra LifeSciences Holdings Corporation (IART) Fifth Amended and Restated 2003 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of IART common stock.

2. RSUs vest in full on the one-year anniversary of the grant date of May 7, 2026. The reporting person elected to defer receipt of the shares underlying the RSUs. In accordance with her deferral election, vested shares will be delivered to the reporting person in one lump sum, in the calendar year next following the calendar year in which the reporting person's termination of service on the Board of Directors occurs (unless the reporting person elected a later calendar year).

Remarks:

	/s/ Michael D. Hutchinson; Attorney-in-Fact for Shaundra Clay	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)